• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by 3M Company

    3/4/25 4:46:53 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email
    FWP 1 tm255161d3_fwp.htm FWP

     

    Filed Pursuant to Rule 433

    Dated March 4, 2025

    Registration Statement No. 333-269639

     

    3M Company

     

    $550,000,000 4.800% Notes due 2030

    $550,000,000 5.150% Notes due 2035

     

    Summary of Terms

     

    4.800% Notes due 2030

       
         
    Issuer:   3M Company
         
    Expected Ratings*:   A3 (Stable) / BBB+ (Stable) / A- (Stable) (Moody’s/S&P/Fitch)
         
    Security Description:   SEC-Registered Fixed Rate Notes
         
    Principal Amount:   $550,000,000
         
    Trade Date:   March 4, 2025
         
    Settlement Date**:   March 13, 2025 (T+7)
         
    Maturity Date:   March 15, 2030
         
    Coupon:   4.800% per annum
         
    Interest Payment Dates:   Payable semi-annually on the 15th day of March and September, beginning September 15, 2025
         
    Regular Record Date:   The 15th calendar day immediately preceding the applicable Interest Payment Date
         
    Day Count Convention:   30/360
         
    Benchmark Treasury:   4.000% due February 28, 2030
         
    Benchmark Treasury Price / Yield:   99-31+ / 4.003%
         
    Re-offer Spread to Benchmark Treasury:  

    T+80 bps

         
    Re-offer Yield:   4.803%
         
    Price to Public:   99.986% of the principal amount
         
    Gross Proceeds:   $549,923,000
         
    CUSIP / ISIN:   88579Y BQ3 / US88579YBQ35
         
    Minimum Denominations:   $2,000 by $1,000

     

     

     

     

    Redemption:   Prior to February 15, 2030 (one month prior to their maturity) (the “Par Call Date”), the Issuer may redeem the notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (1) (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the notes matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 15 basis points, less (b) interest accrued to the date of redemption, and (2) 100% of the principal amount of the notes of such series to be redeemed, plus, in either case, accrued and unpaid interest thereon to the redemption date. In addition, at any time on or after the Par Call Date, the Issuer may redeem the notes in whole or in part, at its option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest thereon to the redemption date.
         

    Joint Book-Running Managers:

     

    BofA Securities, Inc.

    Citigroup Global Markets Inc.

    Deutsche Bank Securities Inc.

    J.P. Morgan Securities LLC

    Barclays Capital Inc.

    BNP Paribas Securities Corp.

    Goldman Sachs & Co. LLC

    Morgan Stanley & Co. LLC

    Wells Fargo Securities, LLC

         
    Co-Managers:  

    Academy Securities, Inc.

    Blaylock Van, LLC

    BNY Mellon Capital Markets, LLC

    HSBC Securities (USA) Inc.

    Loop Capital Markets LLC

    PNC Capital Markets LLC

    RBC Capital Markets, LLC

    R. Seelaus & Co., LLC

    Samuel A. Ramirez & Company, Inc.

    Santander US Capital Markets LLC

    U.S. Bancorp Investments, Inc.

     

    * A security rating is not a recommendation to buy, sell or hold securities and should be evaluated independently of any other rating. The rating is subject to revision or withdrawal at any time.

     

    ** Pursuant to Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one business day unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers of the notes who wish to trade the notes prior to the business day before delivery of the notes will be required, by virtue of the fact that the notes initially will settle in T+7, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement.

     

     

     

     

    5.150% Notes due 2035

       
         
    Issuer:   3M Company
         
    Expected Ratings*:   A3 (Stable) / BBB+ (Stable) / A- (Stable) (Moody’s/S&P/Fitch)
         
    Security Description:   SEC-Registered Fixed Rate Notes
         
    Principal Amount:   $550,000,000
         
    Trade Date:   March 4, 2025
         
    Settlement Date**:   March 13, 2025 (T+7)
         
    Maturity Date:   March 15, 2035
         
    Coupon:   5.150% per annum
         
    Interest Payment Dates:   Payable semi-annually on the 15th day of March and September, beginning September 15, 2025
         
    Regular Record Date:   The 15th calendar day immediately preceding the applicable Interest Payment Date
         
    Day Count Convention:   30/360
         
    Benchmark Treasury:   4.625% due February 15, 2035
         
    Benchmark Treasury Price / Yield:   103-10 / 4.214%
         
    Re-offer Spread to Benchmark Treasury:  

    T+95 bps

         
    Re-offer Yield:   5.164%
         
    Price to Public:   99.891% of the principal amount
         
    Gross Proceeds:   $549,400,500
         

    CUSIP / ISIN:

     

    88579Y BR1 / US88579YBR18

         
    Minimum Denominations:   $2,000 by $1,000
         

    Redemption:

     

    Prior to December 15, 2034 (three months prior to their maturity) (the “Par Call Date”), the Issuer may redeem the notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (1) (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the notes matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 15 basis points, less (b) interest accrued to the date of redemption, and (2) 100% of the principal amount of the notes of such series to be redeemed, plus, in either case, accrued and unpaid interest thereon to the redemption date. In addition, at any time on or after the Par Call Date, the Issuer may redeem the notes in whole or in part, at its option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest thereon to the redemption date. 

     

     

     

     

    Joint Book-Running Managers:

      

    BofA Securities, Inc.

    Citigroup Global Markets Inc.

    Deutsche Bank Securities Inc.

    J.P. Morgan Securities LLC

    Barclays Capital Inc.

    BNP Paribas Securities Corp.

    Goldman Sachs & Co. LLC

    Morgan Stanley & Co. LLC

    Wells Fargo Securities, LLC

         
    Co-Managers:  

    Academy Securities, Inc.

    BNY Mellon Capital Markets, LLC

    HSBC Securities (USA) Inc.

    Loop Capital Markets LLC

    PNC Capital Markets LLC

    RBC Capital Markets, LLC

    R. Seelaus & Co., LLC

    Santander US Capital Markets LLC

    U.S. Bancorp Investments, Inc.

    Blaylock Van, LLC

    Samuel A. Ramirez & Company, Inc.

     

    * A security rating is not a recommendation to buy, sell or hold securities and should be evaluated independently of any other rating. The rating is subject to revision or withdrawal at any time.

     

    ** Pursuant to Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one business day unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers of the notes who wish to trade the notes prior to the business day before delivery of the notes will be required, by virtue of the fact that the notes initially will settle in T+7, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement.

     

     

    No PRIIPs KID – No PRIIPs key information document (KID) has been prepared as not available to retail in the European Economic Area.

     

    The Issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus and prospectus supplement thereto in that registration statement and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling BofA Securities, Inc. at 1-800-294-1322, Citigroup Global Markets Inc. at 1-800-831-9146, Deutsche Bank Securities Inc. at 1-800-503-4611 or J.P. Morgan Securities LLC 1-212-834-4533.

     

     

     

    Get the next $MMM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MMM

    DatePrice TargetRatingAnalyst
    1/16/2026$182.00Overweight → Neutral
    Analyst
    12/8/2025$178.00Buy → Hold
    Deutsche Bank
    10/22/2025$160.00Underweight → Equal-Weight
    Morgan Stanley
    1/22/2025$140.00 → $170.00Equal Weight → Overweight
    Wells Fargo
    11/13/2024$184.00Neutral → Buy
    UBS
    10/22/2024Hold → Buy
    Melius
    9/6/2024$125.00Underweight
    Morgan Stanley
    7/30/2024$145.00Hold → Buy
    Argus
    More analyst ratings

    $MMM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    3M Announces New Board Appointment

    Neil Mitchill elected to the Board of Directors ST. PAUL, Minn., Feb. 5, 2026 /PRNewswire/ -- 3M (NYSE:MMM) announced today the election of Neil G. Mitchill, Jr. to 3M's Board of Directors, effective Feb. 6, 2026. Mr. Mitchill also has been appointed as a member of the Audit Committee and the Nominating and Governance Committee of the Board. Mr. Mitchill is the Executive Vice President and Chief Financial Officer, RTX Corporation. Holding this position since 2021, his responsibilities span financial reporting and controls, planning and analysis, investor relations, internal audit, tax and treasury. Prior to his current role, Mr. Mitchill served as Corporate Vice President of Financial Planni

    2/5/26 8:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Board Declares Quarterly Dividend

    ST. PAUL, Minn., Feb. 3, 2026 /PRNewswire/ -- The 3M Company Board of Directors (NYSE:MMM) today declared a dividend on the company's common stock of $0.78 per share for the first quarter of 2026. The dividend is payable March 12, 2026, to shareholders of record at the close of business on Feb. 13, 2026. 3M has paid dividends to its shareholders without interruption for more than 100 years. About 3M 3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global foo

    2/3/26 4:10:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Submissions open for 3M's nationwide middle school science competition

    Finalists will receive one-to-one mentorship with a 3M scientist, national recognition, and a chance to win top prize: $25,000 and title of "America's Top Young Scientist" ST. PAUL, Minn. and Charlotte, N.C., Jan. 21, 2026 /PRNewswire/ -- 3M (@3M) and Discovery Education today announced that the 2026 3M Young Scientist Challenge (#YoungScientist) is now open to entries. The annual 3M Young Scientist Challenge is the nation's premier middle school science competition. "Every year, the 3M Young Scientist Challenge showcases what's possible when students combine imagination with

    1/21/26 9:05:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    SEC Filings

    View All

    3M Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - 3M CO (0000066740) (Filer)

    2/5/26 8:32:39 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form S-3ASR filed by 3M Company

    S-3ASR - 3M CO (0000066740) (Filer)

    2/3/26 4:50:35 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form IRANNOTICE filed by 3M Company

    IRANNOTICE - 3M CO (0000066740) (Filer)

    2/3/26 4:15:06 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    3M downgraded by Analyst with a new price target

    Analyst downgraded 3M from Overweight to Neutral and set a new price target of $182.00

    1/16/26 8:27:24 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded 3M from Buy to Hold and set a new price target of $178.00

    12/8/25 8:20:58 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded 3M from Underweight to Equal-Weight and set a new price target of $160.00

    10/22/25 6:59:04 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: EVP & Chief HR Officer Dickson Zoe L exercised 20,519 shares at a strike of $142.94 and sold $3,487,614 worth of shares (20,519 units at $169.97) (SEC Form 4)

    4/A - 3M CO (0000066740) (Issuer)

    2/10/26 4:40:16 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    EVP & Chief HR Officer Dickson Zoe L exercised 25,055 shares at a strike of $102.89 and sold $4,267,869 worth of shares (25,055 units at $170.34) (SEC Form 4)

    4 - 3M CO (0000066740) (Issuer)

    2/10/26 4:22:21 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by EVP Chief Strategy Officer Van Wyck Jonathan G.

    4 - 3M CO (0000066740) (Issuer)

    2/10/26 4:12:53 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

    For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

    1/22/21 3:54:10 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Leadership Updates

    Live Leadership Updates

    View All

    Lanvin Group Announces Appointment of New Chief Financial Officer

    SHANGHAI, Oct. 24, 2025 /PRNewswire/ -- Lanvin Group (NYSE:LANV), a global luxury fashion group, today announced the appointment of Mr. Jiyang Han as Chief Financial Officer (CFO) of the Company, effective November 1, 2025. In this role, Mr. Han will oversee the Group's financial affairs, including financial planning and analysis, accounting and controllership, financial management, treasury, investment and financing projects, and investor relations.  Mr. Han brings nearly two decades of experience in corporate finance, investment banking, and global business management. He has served as Co-CIO and Assistant President of Yuyuan (SHSE: 600655) since June 2025. Prior to that, he was the M&A a

    10/24/25 6:00:00 AM ET
    $LANV
    $MMM
    Apparel
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    3M Annual Meeting Results

    ST. PAUL, Minn., May 13, 2025 /PRNewswire/ -- At today's Annual Meeting of Shareholders, 3M (NYSE:MMM) shareholders overwhelmingly supported each of the proposals recommended for approval by the company. Preliminary Shareholder Voting Results 3M shareholders today voted on the following business items: 1) Shareholders supported 11 directors for one-year terms to expire at the company's 2026 Annual Meeting: David P. Bozeman, President, Chief Executive Officer and Director, C.H. Robinson Worldwide, Inc.Thomas "Tony" K. Brown, retired Group Vice President, Global Purchasing, Ford

    5/13/25 4:30:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Announces New Board Appointments

    William Brown to become Chairman of the Board of DirectorsMike Roman to retire as Executive Chairman and Director and become Executive Advisor to the BoardDavid Bozeman elected to the BoardAmy Hood does not intend to stand for reelectionST. PAUL, Minn., Feb. 10, 2025 /PRNewswire/ -- 3M (NYSE:MMM) announced today changes to its Board of Directors and Board leadership structure. William M. "Bill" Brown, 3M's Chief Executive Officer and Director, has been appointed by the Board to serve as its Chairman, effective March 1, 2025 in addition to his current responsibilities.  Michael F. Roman, Executive Chairman of the Board of Directors, has announced his intention to retire as Executive Chairman,

    2/10/25 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/13/24 4:56:03 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/9/23 10:54:46 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/9/22 3:15:56 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Financials

    Live finance-specific insights

    View All

    3M Board Declares Quarterly Dividend

    ST. PAUL, Minn., Feb. 3, 2026 /PRNewswire/ -- The 3M Company Board of Directors (NYSE:MMM) today declared a dividend on the company's common stock of $0.78 per share for the first quarter of 2026. The dividend is payable March 12, 2026, to shareholders of record at the close of business on Feb. 13, 2026. 3M has paid dividends to its shareholders without interruption for more than 100 years. About 3M 3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global foo

    2/3/26 4:10:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Reports Fourth-Quarter and Full-Year 2025 Results; Initiates Full-Year 2026 Financial Guidance

    Q4 GAAP sales of $6.1 billion, up 2.1%; operating margin of 13.0%, down 510 bps; EPS of $1.07, down 20%, all YoYAdjusted sales of $6.0 billion with organic growth of 2.2% YoYAdjusted operating margin of 21.1%, up 140 bps YoYAdjusted EPS of $1.83, up 9% YoYQ4 operating cash flow of $1.6 billion with adjusted free cash flow of $1.3 billionFull-year GAAP sales of $24.9 billion, up 1.5%; operating margin of 18.6%, down 100 bps; EPS of $6.00, down 17%, all YoYAdjusted sales of $24.3 billion with organic growth of 2.1% YoYAdjusted operating margin of 23.4%, up 200 bps YoYAdjusted EPS of $8.06, up 10% YoYFull-year operating cash flow of $2.3 billion with adjusted free cash flow of $4.4 billionST. P

    1/20/26 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Announces Upcoming Investor Event

    ST. PAUL, Minn., Jan. 6, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today announced the following investor event: Fourth-quarter 2025 earnings conference call on Tuesday, Jan. 20, 2026, at 8 a.m. CT.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com. About 3M3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3

    1/6/26 10:15:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care